Bank of Nova Scotia Trust’s Zimmer Biomet ZBH Stock Holding History

Bank of Nova Scotia Trust’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-989	Closed	-$112K	–	412
2017 Q3	$112K	Buy	+989	New	+$114K	0.01%	172

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of Nova Scotia Trust's ZBH Position: Q4 2017 in Review

Bank of Nova Scotia Trust sold out of Zimmer Biomet (ZBH) in Q4 2017, closing a stake of 989 shares — an estimated $112K sold.

Bank of Nova Scotia Trust first reported a position in ZBH in Q3 2017 and held it in 1 quarter. The position peaked at $112K in Q3 2017. 870 funds tracked by Wall St. Rank hold ZBH as of Q4 2017.

Bank of Nova Scotia Trust reported no remaining Zimmer Biomet position as of Q4 2017 after selling out during the quarter.
Bank of Nova Scotia Trust sold 989 Zimmer Biomet shares in Q4 2017, an estimated $112K.
Bank of Nova Scotia Trust first reported a position in Zimmer Biomet in Q3 2017 and held it in 1 quarter.
Bank of Nova Scotia Trust's Zimmer Biomet position peaked at $112K in Q3 2017.
870 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2017.

Based on Bank of Nova Scotia Trust's 13F filing for Q4 2017, filed 13 Feb 2018.